Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention

Published:2024-05-02 Issue:7 Volume:25 Page:293-298
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Park Joshua J¹^ORCID,Cabel Gervacio Y¹,Cheng Kevin K¹^ORCID,Dang Jefferson¹,Ardati Amer K²,Han Jin³^ORCID,Lee James C³^ORCID

Affiliation:

1. University of Illinois Chicago College of Pharmacy, Chicago, IL 60612, USA

2. Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA

3. Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, IL 60612, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14622416.2024.2355862

Reference21 articles.

1. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

2. Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients

3. Cytochrome P-450 Polymorphisms and Response to Clopidogrel

4. Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

5. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP